| . | <1 month . | 1–3 months . | >3 months . | |||
|---|---|---|---|---|---|---|
| Number of studies . | Short-term angiographic patency . | Number of studies . | Intermediate-term angiographic patency . | Number of studies . | Long-term angiographic patency . | |
| MVP | 6 | 96.8% (60/62) | – | – | 2 | 88.5% (23/26) |
| Heartflo | 1 | 100% (6/6)) | – | – | – | – |
| St Jude | 4 | 100% (57/57) | 2 | 91.3% (21/23) | 2 | 73% (27/37) |
| U-Clip | 1 | 95.1% (96/101) | – | – | 4 | 96.1% (123/128) |
| VCS | 1 | 92.3% (12/13) | 1 | 100% (3/3) | – | – |
| DAD | 1 | 92.9% (13/14) | – | – | – | – |
| C-Port | 1 | 99.1% (106/107) | 2 | 94.5% (52/55) | 4 | 93.8% (213/227) |
| CAC | – | – | 1 | 96.7% (29/30) | – | – |
| Overall device patency | 15 | 97.2% (350/360) | 6 | 94.6% (105/111) | 12 | 92.3% (386/418) |
| Overall hand-sewn patency | 3 | 94.8% (145/153) | 2 | 93.4% (57/61) | 3 | 95.1% (97/102) |
| . | <1 month . | 1–3 months . | >3 months . | |||
|---|---|---|---|---|---|---|
| Number of studies . | Short-term angiographic patency . | Number of studies . | Intermediate-term angiographic patency . | Number of studies . | Long-term angiographic patency . | |
| MVP | 6 | 96.8% (60/62) | – | – | 2 | 88.5% (23/26) |
| Heartflo | 1 | 100% (6/6)) | – | – | – | – |
| St Jude | 4 | 100% (57/57) | 2 | 91.3% (21/23) | 2 | 73% (27/37) |
| U-Clip | 1 | 95.1% (96/101) | – | – | 4 | 96.1% (123/128) |
| VCS | 1 | 92.3% (12/13) | 1 | 100% (3/3) | – | – |
| DAD | 1 | 92.9% (13/14) | – | – | – | – |
| C-Port | 1 | 99.1% (106/107) | 2 | 94.5% (52/55) | 4 | 93.8% (213/227) |
| CAC | – | – | 1 | 96.7% (29/30) | – | – |
| Overall device patency | 15 | 97.2% (350/360) | 6 | 94.6% (105/111) | 12 | 92.3% (386/418) |
| Overall hand-sewn patency | 3 | 94.8% (145/153) | 2 | 93.4% (57/61) | 3 | 95.1% (97/102) |
CAC: coronary anastomosis coupler; VCS: vessel closure system; DAD: distal anastomotic device; MVP: magnetic vascular positioner.
| . | <1 month . | 1–3 months . | >3 months . | |||
|---|---|---|---|---|---|---|
| Number of studies . | Short-term angiographic patency . | Number of studies . | Intermediate-term angiographic patency . | Number of studies . | Long-term angiographic patency . | |
| MVP | 6 | 96.8% (60/62) | – | – | 2 | 88.5% (23/26) |
| Heartflo | 1 | 100% (6/6)) | – | – | – | – |
| St Jude | 4 | 100% (57/57) | 2 | 91.3% (21/23) | 2 | 73% (27/37) |
| U-Clip | 1 | 95.1% (96/101) | – | – | 4 | 96.1% (123/128) |
| VCS | 1 | 92.3% (12/13) | 1 | 100% (3/3) | – | – |
| DAD | 1 | 92.9% (13/14) | – | – | – | – |
| C-Port | 1 | 99.1% (106/107) | 2 | 94.5% (52/55) | 4 | 93.8% (213/227) |
| CAC | – | – | 1 | 96.7% (29/30) | – | – |
| Overall device patency | 15 | 97.2% (350/360) | 6 | 94.6% (105/111) | 12 | 92.3% (386/418) |
| Overall hand-sewn patency | 3 | 94.8% (145/153) | 2 | 93.4% (57/61) | 3 | 95.1% (97/102) |
| . | <1 month . | 1–3 months . | >3 months . | |||
|---|---|---|---|---|---|---|
| Number of studies . | Short-term angiographic patency . | Number of studies . | Intermediate-term angiographic patency . | Number of studies . | Long-term angiographic patency . | |
| MVP | 6 | 96.8% (60/62) | – | – | 2 | 88.5% (23/26) |
| Heartflo | 1 | 100% (6/6)) | – | – | – | – |
| St Jude | 4 | 100% (57/57) | 2 | 91.3% (21/23) | 2 | 73% (27/37) |
| U-Clip | 1 | 95.1% (96/101) | – | – | 4 | 96.1% (123/128) |
| VCS | 1 | 92.3% (12/13) | 1 | 100% (3/3) | – | – |
| DAD | 1 | 92.9% (13/14) | – | – | – | – |
| C-Port | 1 | 99.1% (106/107) | 2 | 94.5% (52/55) | 4 | 93.8% (213/227) |
| CAC | – | – | 1 | 96.7% (29/30) | – | – |
| Overall device patency | 15 | 97.2% (350/360) | 6 | 94.6% (105/111) | 12 | 92.3% (386/418) |
| Overall hand-sewn patency | 3 | 94.8% (145/153) | 2 | 93.4% (57/61) | 3 | 95.1% (97/102) |
CAC: coronary anastomosis coupler; VCS: vessel closure system; DAD: distal anastomotic device; MVP: magnetic vascular positioner.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
